BB ) provides a strong low cost system of broad base US
national marketing, sales and distribution of generic Rx, branded Rx, OTC, nutraceuticals, and oral delivery
OTC pharmaceuticals through mass merchants, super markets, chain drug stores, independent drug stores,
hospitals, long term care, HMO’s, home health care, clinics, PBM’s, State and Federal Government (Department
of Veterans Affairs, Department of Defense).
This strong marketing platform can provide a launch pad for immediately introducing ANDAs for any global
company. “Pull Through” network of the Company results in strong customer retention, low cost and access to wide
The Company has strong relationships with local customers and deep understanding of and ability to serve
customer needs. These relationships with ScripsAmerica will allow the Company to acquire a
substantial shelf space for its products in very short span of time.
The Company caters to a large base of customers without carrying substantial inventory. This demonstrates
ScripsAmerica’s ability of flawless execution of management in a pure generic market. Going forward, with the
increase in the revenue and customer base, the Company is focused on ensuring strict control on its inventory, at
the same time achieving minimum turnaround time.
Market Cap: $15.8M
S/O: 56.5M (3 ppl own 79%)
Funding to Date: $2.5 mil
‐ Pref. Conv.: $1.1 mil @ .175
‐ Conv. Debt: $975k @ .25
‐ Other: $453k 4 Year Term
Structure: Delaware C-Corp